"K-Medical Products Commercialization Support" MFDS Launches 'Global Expert Advisory Group'

The Ministry of Food and Drug Safety announced on the 24th that it has launched the ‘Global Expert Advisory Group,’ composed of world-renowned experts, to support the rapid commercialization of medical products amid the increasing development of medical products using the latest technologies.

The Global Expert Advisory Group consists of 15 international experts with regulatory experience or current involvement in various fields, including ▲cell and gene therapies ▲drug and gene delivery ▲diagnostic medical devices ▲consultation on approvals and reviews by overseas regulatory agencies. The term of office is two years.

The scope of consultation includes technical advice on pre-review and approval and review issues related to medical products such as pharmaceuticals, biopharmaceuticals, and medical devices. When consultation is needed, written or video meetings will be held as necessary.

Oh Yu-kyung, Commissioner of the Ministry of Food and Drug Safety, stated, “With the launch of this advisory group composed of world-class experts with specialized capabilities in cutting-edge technologies, we expect to complement and strengthen the Ministry’s expertise and significantly contribute to domestic medical products securing a leading position in the global market and enhancing export competitiveness.”

Meanwhile, the advisory members will also participate as speakers at the ‘2023 Global Bio Conference (GBC),’ hosted by the Ministry of Food and Drug Safety in Seoul from the 30th of this month to the 1st of next month, to share the latest trends in medical product development.

Bio-related image. Not directly related to the article.

This content was produced with the assistance of AI translation services.